Gema Hernández

ORCID: 0000-0003-4832-455X · 6 papers in corpus
2025
Hormonal Therapy For Endometriosis And The Risk Of Endometriosis-Associated Gynecologic Cancers: A Propensity Score-Adjusted Real-World Data Study
·doi:10.1016/j.ijgc.2024.100369
2025
Hormonal Therapy In Endometriosis And Breast Cancer Risk: A Propensity Score-Matched Real-World Analysis
·doi:10.1016/j.ijgc.2024.101267
observational 2025
Real-world assessment of breast cancer risk following hormonal therapy in endometriosis: A Global Collaborative Network propensity score matched analysis.
·doi:10.1200/jco.2025.43.16_suppl.11143

11143 Background: Research suggests endometriosis, an estrogen-dependent condition, may be a potential risk factor for breast cancer (BC) development. While oral contraceptives are the standard treatment, their efficacy is limited in sympto…

observational 2024
Endometriosis and endometrial cancer: A propensity score-adjusted real-world data study
iScience ·doi:10.1016/j.isci.2024.109680

Endometriosis is a benign condition characterized by the presence of ectopic endometrial tissue. Our study investigated the effect of endometriosis on the risk of endometrial cancer (EC) and the prognosis of endometriosis-associated EC. In …

2023
#434 Association between endometriosis and endometrial cancer: a real world evidence study
·doi:10.1136/ijgc-2023-esgo.55
observational 2023
Adenomyosis in Pregnancy-Should It Be Managed in High-Risk Obstetric Units?
Diagnostics ·doi:10.3390/diagnostics13061184

BACKGROUND: Uterine adenomyosis is an increasingly frequent disorder. Our study aimed to demonstrate the presence of obstetric complications in the population affected by this condition to demonstrate the need for follow-up in high-risk obs…